Azathioprine versus Mycophenolate Mofetil, Comparing Effectiveness for Treatment of Generalized Myasthenia Gravis

episode

American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

A Blue Wave?, Xi’s Visit, Trump vs. the Press, Diesel Prices 55 min · 26 Sep 2026 · The Politics Guys

Introducing What Could Go Right? 1 min · 26 Sep 2026 · The Politics Guys

What is Utopia? Presenting The Receipt Horizon, by Joel Borgen – Chapters 1–4 2h 50m · 26 Sep 2026 · "The Cognitive Revolution"

Science with Luke: Ultra-Processed Food 10 min · 26 Sep 2026 · The Pat Kenny Show

NPR News: 09-26-2026 7AM EDT 4 min · 26 Sep 2026 · NPR News Now

7AM ET 09/26/2026 Newscast 3 min · 26 Sep 2026 · Fox News Hourly Update

Report any issue

Source

Recorded15 Jul 2026

Publisheranchor.fm ↗

Handlerec:19298354

Show notes

Curious about which immunosuppressant is most efficacious for treatment of Myasthenia Gravis? In this episode, Vonda Elmer, R. EEG/EP. T, R. NCS. T, CNCT will talk with Donald Sanders, MD, professor emeritus of neurology at Duke University School of Medicine and lead author of the recently published data from The Duke MG Patient Registry comparing the effectiveness of Azathioprine and Mycophenolate Mofetil in generalized Myesthenia Gravis. Dr. Sanders will share the details and findings of this interesting retrospective single-center review.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in